8-K Apogee Therapeutics, Inc. 2026-09-03: filing_items
| Value | {"items": {"1.02": "Termination of a Material Definitive Agreement", "2.01": "Completion of Acquisition or Disposition of Assets", "3.01": "Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing", "3.03": "Material Modification to Rights of Security Holders", "5.01": "Changes in Control of Registrant", "5.02": "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers", "5.03": "Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year", "9.01": "Financial Statements and Exhibits"}, "value": "1.02,2.01,3.01,3.03,5.01,5.02,5.03,9.01"} |
|---|---|
| Period | (as of 2026-09-03) |
| Status | current |
| Entity | 8-K Apogee Therapeutics, Inc. 2026-09-03 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference:
Retrieved: 2026-09-03T15:09:21.562834+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/949e7e27-8ea7-425e-b5fd-bf8709767e03
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference:
https://www.sec.gov/Archives/edgar/data/1974640/000114036126035537/0001140361-26-035537-index.htmRetrieved: 2026-09-03T15:09:21.562834+02:00
Raw response sha256:
f4b06ee0895c34b1282a5eed0dccfe1d…Cite as: FACTANKER, https://factanker.com/fact/949e7e27-8ea7-425e-b5fd-bf8709767e03
History
- no predecessors — first report